
Amgen
North America, California, United States, Thousand Oaks
Description
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Investor Profile
Amgen has backed more than 18 startups, with 0 new investments in the last 12 months alone. The firm has led 7 rounds, about 39% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Corporate Round, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Germany, Israel.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (17%)
- Corporate Round (17%)
- Post Ipo Equity (11%)
- Non Equity Assistance (11%)
- Series Unknown (11%)
- Series E (11%)
- Series C (6%)
- Grant (6%)
- Post Ipo Debt (6%)
- Series A (6%)
Country Focus
- United States (78%)
- Germany (11%)
- Israel (6%)
- United Kingdom (6%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Health Diagnostics
- Enterprise Software
- Medical Device
- Analytics
- Data Integration
- Database
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Amgen frequently co-invest with?
Which angels does Amgen often collaborate with?
What are some of recent deals done by Amgen?
Find More Investors Like Amgen
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides











